Tuberculosis
-
Confronting TB resistance
Vanderbilt researchers describe how certain tuberculosis treatments work and suggest these medications may overcome the threat of drug-resistant tuberculosis. Read MoreJun 11, 2018
-
An unexpected side effect of public health education efforts in Brazil
Understanding of tuberculosis is associated with higher, not lower, stigmatization of TB patients in Brazil, according to a new report from Vanderbilt’s Latin American Public Opinion Project. Read MoreMar 20, 2018
-
HIV treatment and TB risk
Tuberculosis (TB) remains an important public health problem, particularly among people infected with the human immunodeficiency virus (HIV). Read MoreAug 4, 2016
-
Study explores gene’s role in protecting HIV patients from TB
An international research team led by scientists from Vanderbilt University Medical Center has identified a genetic variant that protects people with HIV from developing active tuberculosis. The variant is near the gene encoding the infection-fighting cytokine IL-12. Read MoreMar 17, 2016
-
Slight chemical change may improve TB treatments: study
One small chemical change to an existing antibacterial drug results in a compound that is more effective against its target enzyme in tuberculosis, Vanderbilt researchers have discovered. Read MoreFeb 11, 2016
-
HHMI, Gates Foundation and Simons Foundation 2016 Faculty Scholars Competition
Vanderbilt is one of 220 institutions whose scholars are invited to apply to a new competition. Read MoreMar 26, 2015
-
Routine TB testing to resume Dec. 16
Routine tuberculosis (TB) skin testing for Vanderbilt staff and faculty will resume Monday, Dec. 16, after temporarily being suspended since September due to a national shortage of the TB skin testing solution Tubersol. Read MoreDec 12, 2013
-
Preserving antibiotic arsenal for TB
Clinicians should be cautious about prescribing newer fluoroquinolone antibiotics to patients with TB risk factors; doing so may jeopardize the use of these agents against TB. Read MoreOct 30, 2013
-
Shortage forces suspension of routine tuberculosis testing
Due to a national shortage of the tuberculosis (TB) test solution Tubersol, Occupational Health will temporarily suspend routine annual skin tests, effective Sept. 1, said Patricia Kinman, MSN, FNP-BC, manager of the Vanderbilt Occupational Health Clinic Read MoreAug 29, 2013
-
Study lays groundwork for rational T cell vaccine design
Vanderbilt University investigators have developed a new strategy for identifying the “bits” of a pathogen that spark a protective immune response. Read MoreMay 30, 2013
-
TB skin testing resumes for VU faculty, staff
Routine TB skin testing, offered through Vanderbilt University Medical Center’s Occupational Health Clinic, has resumed, effective immediately. Read MoreMay 9, 2013
-
National shortage forces hiatus in routine TB testing
Due to an unprecedented national shortage of the tuberculosis (TB) skin testing solution Tubersol, Vanderbilt University Medical Center has temporarily paused routine skin testing of health care workers. Read MoreApr 11, 2013
-
New center to focus on treating, preventing TB
Vanderbilt University has established a tuberculosis center to expand and extend efforts to improve the treatment and prevention of this often fatal disease here and around the world. Read MoreMar 14, 2013
-
Early HIV treatment also can prevent TB: study
Anti-retroviral therapy can prevent tuberculosis, even in people with early HIV disease. Read MoreAug 2, 2012
-
Study leads to simpler therapy for treating latent tuberculosis
Research led by Timothy Sterling, professor of medicine, has led to an important change in The Centers for Disease Control and Prevention's recommendations in the regimen for prevention of the centuries-old scourge, tuberculosis. Read MoreDec 9, 2011
-
Investigator’s work leads to simpler latent TB therapy
New research on tuberculosis offers an important development in preventing the centuries-old disease. Read MoreJul 29, 2011
-
Elephants can transmit TB to humans
Elephants can transmit TB to humans, researchers at the CDC, Tennessee Department of Health and Vanderbilt University have reported. Read MoreMar 11, 2011